Lineage Cell Therapeutics
LCTX
#8577
Rank
S$0.20 B
Marketcap
$0.90
Share price
-2.52%
Change (1 day)
-36.61%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -S$30.27 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$8.71 Million. In 2023 the company made an earning of -S$33.05 Million a decrease over its 2022 earnings that were of -S$30.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$30.27 Million-8.4%
2023 -S$33.05 Million9.83%
2022 -S$30.09 Million-54.24%
2021 -S$65.75 Million86.07%
2020 -S$35.34 Million-31.97%
2019 -S$51.94 Million-5.42%
2018 -S$54.91 Million1.1%
2017 -S$54.32 Million-31.06%
2016 -S$78.78 Million-10.38%
2015 -S$87.91 Million29.69%
2014 -S$67.79 Million31.68%
2013 -S$51.48 Million
2011 -S$24.99 Million89.78%
2010 -S$13.17 Million206.06%
2009 -S$4.31 Million-0.58%
2008 -S$4.33 Million164.89%
2007 -S$1.64 Million-30.22%
2006 -S$2.35 Million
2002 -S$2.72 Million-41.04%
2001 -S$4.61 Million-32.04%
2000 -S$6.79 Million-11.85%
1999 -S$7.7 Million
1997 -S$4.95 Million12.12%
1996 -S$4.41 Million106.25%
1995 -S$2.14 Million-11.11%
1994 -S$2.41 Million50%
1993 -S$1.61 Million20%
1992 -S$1.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA